Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice
- PMID: 18402905
- PMCID: PMC3095112
- DOI: 10.1016/j.jacc.2008.01.015
Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice
Abstract
Objectives: This study sought to evaluate whether increased left ventricular (LV) adenylyl cyclase VI (AC(VI)) expression, at a time when severe congestive heart failure (CHF) was present, would increase function of the actively failing heart.
Background: Increased LV AC(VI) content markedly reduces mortality and increases LV function after acute myocardial infarction (MI) in mice. However, the effects of increased cardiac AC(VI) content in the setting of severe heart failure caused by ischemic cardiomyopathy are unknown.
Methods: Mice with cardiac-directed and regulated expression of AC(VI) underwent coronary artery ligation to induce severe CHF 5 weeks later. AC(VI) expression was then activated in 1 group (AC-On) but not the other (AC-Off). Multiple measures of LV systolic and diastolic function were obtained 5 weeks later, and LV samples were assessed for alterations in calcium and beta-adrenergic receptor signaling, apoptosis, and cardiac troponin I phosphorylation.
Results: The LV systolic and diastolic function was increased 5 weeks after activation of AC(VI) expression. Improved LV function was associated with normalization of cardiac troponin I phosphorylation and reduced apoptosis.
Conclusions: Activation of cardiac AC(VI) expression in mice with ischemic cardiomyopathy and severe CHF improves function of the failing heart.
Figures
References
-
- Takahashi T, Tang T, Lai NC, et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation. 2006;114:388–96. - PubMed
-
- Lai NC, Roth DM, Gao MH, et al. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation. 2004;110:330–6. - PubMed
-
- Roth DM, Gao MH, Lai NC, et al. Cardiac-directed adenylylcyclase expression improves heart function in cardiomyopathy. Circulation. 1999;99:3099–102. - PubMed
-
- Roth DM, Bayat H, Drumm D, et al. Adenylyl cyclase increases survival in cardiomyopathy. Circulation. 2002;105:1989–94. - PubMed
-
- Hoshijima M, Ikeda Y, Iwanaga Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med. 2002;8:864–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
